AbbVie   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lake Bluff IL United States (2013)

Organization Overview

First Clinical Trial
2013
NCT00195663
First Marketed Drug
2013
dicoumarol
First NDA Approval
2014
dasabuvir (Exviera)
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Abbvie | AbbVie | ABBVIE | AbbVie AB | AbbVie Clinical Pharmacology Research Unit (ACPRU) | AbbVie Corporation | ABBVIE ENDOCRINE | ABBVIE ENDOCRINE INC | AbbVie GK | AbbVie GK. | ABBVIE INC | AbbVie Japan | AbbVie Japan Co., Ltd | AbbVie Laboratories | AbbVie LC | AbbVie (prior sponsor, Abbott) | AbbVie_Stemcentrx | AbbVie Study-Designated Physician | Medical Affairs, AbbVie Sweden AB | ORGANICS LAGRANGE